Search Within

Population Sciences Research Program

  1. "Biostatistics Service"
  2. "Center for Hematologic Malignancies"
  3. "Master of Science in Clinical and Translational Cancer Research "
  4. "Nursing"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (3)
  3. Research Letter (1)
Groups
  1. Biostatistics Service (9)
  2. CTCR Scholars (9)
  3. Center for Hematologic Malignancies (9)
  4. Department of Medicine (9)
  5. Epidemiology and Biostatistics (9)
  6. Hematologic Malignancies, Division of (9)

More Groups

People
  1. Craig Sauter (6)
  2. Miguel-Angel Perales (6)
  3. Parastoo Dahi (6)
  4. Ariela Noy (5)
  5. Maria Palomba (5)
  6. Sergio Giralt (5)

More People

Years
  1. 2021 (2)
  2. 2020 (4)
  3. 2019 (1)
  4. 2017 (1)
  5. 2016 (1)
Publications
  1. Blood (4)
  2. Blood Advances (1)
  3. Haematologica (1)
  4. Journal of Clinical Oncology (1)
  5. Journal of Palliative Medicine (1)
  6. Leukemia and Lymphoma (1)
Publishers
  1. American Society of Hematology (5)
  2. American Society of Clinical Oncology (1)
  3. Ferrata Storti Foundation (1)
  4. Mary Ann Liebert, Inc (1)
  5. Taylor & Francis Group (1)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
    Journal Article

    Bewersdorf, J. P.; Derkach, A.; Gowda, L.; Menghrajani, K.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma
    Research Letter

    Lin, R. J.; Lobaugh, S. M.; Pennisi, M.; Chan, H. T.; Batlevi, Y.; Ruiz, J. D.; Elko, T. A.; Maloy, M. A.; Batlevi, C. L.; Dahi, P. B.; more...
    Haematologica (2021)

    Fulltext@MSK | Save
  • Clinical outcomes of acute myeloid leukemia patients bridged to allogeneic stem cell transplant by venetoclax combination therapy
    Meeting Abstract

    Stahl, M.; Menghrajani, K.; Derkach, A.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; Barker, J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Early data from a phase II trial investigating the combination of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (HL)
    Meeting Abstract

    Sermer, D. J.; Vardhana, S. A.; Ames, A.; Biggar, E.; Moskowitz, A. J.; Batlevi, C. L.; Caron, P.; Hamilton, A. M.; Moskowitz, C. H.; Matasar, M. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Characteristics and impact of post-transplant interdisciplinary palliative care consultation in older allogeneic hematopoietic cell transplant recipients
    Journal Article

    Lin, R. J.; Cohen, A. G.; Stabler, S. M.; Devlin, S. M.; Elko, T. A.; Maloy, M. A.; Korc-Grodzicki, B.; Alexander, K.; Kramer, D.; Sanchez-Escamilla, M.; more...
    Journal of Palliative Medicine (2020)

    Fulltext@MSK | Save
  • Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies
    Journal Article

    Sermer, D.; Batlevi, C.; Lia Palomba, M.; Shah, G.; Lin, R. J.; Perales, M. A.; Scordo, M.; Dahi, P.; Pennisi, M.; Afuye, A.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Impact and safety of chimeric antigen receptor T cell therapy in vulnerable older patients with relapsed/refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Lin, R. J.; Lobaugh, S. M.; Pennisi, M.; Chan, J. T.; Batlevi, Y.; Ruiz, J. D.; Elko, T. A.; Maloy, M. A.; Batlevi, C. L.; Dahi, P. B.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • A phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory B-and T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M. A.; Lynch, P.; Scheuerman, M.; Minnal, V.; Galasso, N.; Kumar, A.; Gerecitano, J.; Zelenetz, A. D.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • A Phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M.; Lynch, P.; Scheuerman, M.; Kumar, A.; Gerecitano, J. F.; Zelenetz, A. D.; Hamlin, P. A. Jr; Noy, A.; more...
    Blood (2016)

    Fulltext@MSK | Save